国家医保局出台新规 手术机器人等医疗服务有了“明码标价”

Core Viewpoint - The National Healthcare Security Administration (NHSA) has released a guideline to standardize pricing for surgical and treatment auxiliary services, addressing the challenge of charging for advanced medical technologies like surgical robots and 3D bioprinting [1][2]. Group 1: Pricing Guidelines - The guideline establishes 37 pricing items, including 5 additional charges and 1 expansion item, covering key technologies such as 3D printing, surgical robots, and remote surgeries [1]. - A specific pricing project for bioprinting has been created to facilitate the transition from concept testing to clinical application, promoting the use of organ-like technologies [1]. - The guideline introduces a tiered pricing model for surgical robots based on their level of involvement and clinical value, allowing for higher fees for more advanced functionalities [2]. Group 2: Impact on Companies - Companies involved in 3D bioprinting have expressed that the guideline significantly aids their operations, as the lack of standardized pricing previously hindered clinical entry and long-term development [1]. - The guideline is expected to encourage innovation and shorten the promotion cycle for new technologies, benefiting domestic supply chains and reducing costs [2]. - The release of the guideline is anticipated to resolve clinical translation issues for innovative technologies, allowing patients to benefit from advancements while promoting high-quality development in the medical equipment industry [2]. Group 3: Remote Surgery - The guideline includes a pricing project for remote surgical assistance, enabling experts in resource-rich areas to provide services to patients in other regions, thus alleviating the burden of seeking medical care from afar [3]. - A notable achievement in remote surgery was highlighted, where a team successfully performed a prostate cancer surgery over a distance of 8,100 kilometers using a domestic surgical robot [3]. - The market share of domestic laparoscopic surgical robots is projected to grow significantly, from 32.61% in 2023 to 48.89% in 2024, indicating a strong potential for future expansion [3].